The blood test, Called PanSeer, detected cancer in 91% of people who had been asymptomatic when the samples were collected and were diagnosed with cancer one to four years later.
The prevalence of antibodies for people recovering from a mild cases of COVID-19 dropped precipitously after less than three months, according to a research letter published this week in The New England Journal of Medicine.
The Centers for Disease Control and Prevention National Healthcare Safety Network COVID-19 module will no longer be an option for daily reporting, effective July 15, the Department of Health and Human Services announced.
The Joint Commission again has earned CMS approval as a national accrediting organization for hospitals, but only for two years. Expect more changes as CMS continues to express concerns about TJC's performance.
